These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16796758)

  • 21. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
    Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
    Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
    Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
    J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
    Williams LA; Casbas-Hernandez P; Nichols HB; Tse CK; Allott EH; Carey LA; Olshan AF; Troester MA
    PLoS One; 2019; 14(1):e0211488. PubMed ID: 30682163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast carcinoma in situ: risk factors and screening patterns.
    Claus EB; Stowe M; Carter D
    J Natl Cancer Inst; 2001 Dec; 93(23):1811-7. PubMed ID: 11734598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
    Grimm LJ; Miller MM; Thomas SM; Liu Y; Lo JY; Hwang ES; Hyslop T; Ryser MD
    Radiology; 2019 Jul; 292(1):77-83. PubMed ID: 31112087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
    Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
    J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
    Maskarinec G; Dartois L; Delaloge S; Hopper J; Clavel-Chapelon F; Baglietto L
    Cancer Epidemiol; 2017 Aug; 49():156-160. PubMed ID: 28697417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of mammography in predicting histological extent of ductal carcinoma in situ (DCIS).
    Chakrabarti J; Evans AJ; James J; Ellis IO; Pinder SE; Macmillan RD
    Eur J Surg Oncol; 2006 Dec; 32(10):1089-92. PubMed ID: 16872800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are breast density and bone mineral density independent risk factors for breast cancer?
    Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
    J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnic and geographic differences in mammographic density and their association with breast cancer incidence.
    Maskarinec G; Pagano I; Chen Z; Nagata C; Gram IT
    Breast Cancer Res Treat; 2007 Jul; 104(1):47-56. PubMed ID: 17009106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammographic density and risk of breast cancer by age and tumor characteristics.
    Bertrand KA; Tamimi RM; Scott CG; Jensen MR; Pankratz V; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
    Breast Cancer Res; 2013 Nov; 15(6):R104. PubMed ID: 24188089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
    Lee SJ; Li X; Huang H; Zelen M
    Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding.
    Tan PH
    Ann Acad Med Singap; 2001 Nov; 30(6):671-6; quiz 677. PubMed ID: 11817303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.